GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity.

GR 20263 is a new broad-spectrum injectable cephalosporin which is stable to most beta-lactamases. Its in vitro activities were of the same order as those of cefotaxime against most gram-negative bacteria, were clearly inferior to cefotaxime against Staphylococcus aureus, but were significantly more...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: O'Callaghan, C H, Acred, P, Harper, P B, Ryan, D M, Kirby, S M, Harding, S M
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1980
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283891/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6994642/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.5.876
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items